Cargando…
Probable Treatment Targets for Diabetic Retinopathy Based on an Integrated Proteomic and Genomic Analysis
PURPOSE: Using previously approved medications for new indications can expedite the lengthy and expensive drug development process. We describe a bioinformatics pipeline that integrates genomics and proteomics platforms to identify already-approved drugs that might be useful to treat diabetic retino...
Autores principales: | Valdivia, Anddre Osmar, He, Ye, Ren, Xinjun, Wen, Dejia, Dong, Lijie, Nazari, Hossein, Li, Xiaorong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Association for Research in Vision and Ophthalmology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9910385/ https://www.ncbi.nlm.nih.gov/pubmed/36745438 http://dx.doi.org/10.1167/tvst.12.2.8 |
Ejemplares similares
-
Proteomic Analysis of Early Diabetic Retinopathy Reveals Mediators of Neurodegenerative Brain Diseases
por: Sundstrom, Jeffrey M., et al.
Publicado: (2018) -
Targeted Blood Metabolomic Study on Retinopathy of Prematurity
por: Yang, Yuhang, et al.
Publicado: (2020) -
Arginine and Carnitine Metabolites Are Altered in Diabetic Retinopathy
por: Sumarriva, Katherine, et al.
Publicado: (2019) -
The Impact of Diabetic Retinopathy on the Choriocapillaris in Neovascular AMD
por: Viggiano, Pasquale, et al.
Publicado: (2023) -
Evidence for Structural and Functional Damage of the Inner Retina in Diabetes With No Diabetic Retinopathy
por: Montesano, Giovanni, et al.
Publicado: (2021)